Abiogen Pharma signed agreement with Lee's Pharma to market Neridronic Acid in mainland China, Taiwan, Hong Kong and Macau

摘要

Abiogen Pharma S.p.A. of Pisa Italy and Lee's Pharm have signed a License, Distribution and Supply agreement for marketing of Attila~R (Neridronic Acid) throughout mainland China, Hong Kong, Macau and Taiwan. Under the term of the agreement, Abiogen Pharma S.p.A. grantedLee's Pharm an exclusive license and right for registering, importing, marketing, distributing and selling Attila~R in the territory, for the two orphan/rare disease indications Osteogenesis Imperfecta (01) and Complex Regional Pain Syndrome (CRPS).